--- title: "Daily Hong Kong Stock Market News Briefing (December 16, Monday)" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/222379230.md" description: "Daily Hong Kong Stock Market News Brief: R&F PROPERTIES had a contract sales amount of RMB 1 billion in November, with a cumulative total of RMB 10.19 billion from January to November; SHIMAO GROUP received 80.72% creditor support for restructuring; Guming Holdings resubmitted pre-listing documents; Ping An Insurance's premium income for the first eleven months reached RMB 796.3966 billion, a year-on-year increase of 7.86%; NCI's premium income for the first eleven months was RMB 163.1663 billion, a year-on-year increase of 2.2%; China Shenhua's coal sales volume for the first eleven months was 422 million tons, a year-on-year increase of 3%; Ganfeng Lithium's Goulamina lithium spodumene project commenced production; Shijiazhuang Fourth Pharmaceutical Group's related drugs were approved by the National Medical Products Administration" datetime: "2024-12-16T01:05:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/222379230.md) - [en](https://longbridge.com/en/news/222379230.md) - [zh-HK](https://longbridge.com/zh-HK/news/222379230.md) --- > 支持的语言: [English](https://longbridge.com/en/news/222379230.md) | [繁體中文](https://longbridge.com/zh-HK/news/222379230.md) # Daily Hong Kong Stock Market News Briefing (December 16, Monday) Individual Stock News 1. R&F PROPERTIES (02777.HK): Contract sales in November amounted to RMB 1 billion, with cumulative contract sales from January to November reaching RMB 10.19 billion. 2. SHIMAO GROUP (00813.HK): Creditors holding 80.72% of the debt principal within the scope support the restructuring. 3. On December 15, Gu Ming Holdings re-submitted its pre-listing documents to the Hong Kong Stock Exchange. 4. Ping An Insurance (02318.HK): The total premium income from original insurance contracts for the first 11 months was approximately RMB 796.3966 billion, a year-on-year increase of 7.86%. 5. NCI (01336.HK): The cumulative original premium income for the first 11 months was RMB 163.1663 billion, a year-on-year increase of 2.2%. 6. CSEC/China Shenhua (01088.HK): Coal sales for the first 11 months reached 422 million tons, a year-on-year increase of 3%. 7. Ganfeng Lithium (01772.HK): The first phase of the Goulamina spodumene project has officially commenced production. 8. Stone Four Pharmaceutical Group (02005.HK): Fumaric acid vorinostat and hydrochloride decitabine have been approved for registration by the National Medical Products Administration as raw materials for use in marketed formulations ### 相关股票 - [NCI (601336.CN)](https://longbridge.com/zh-CN/quote/601336.CN.md) - [NCI (01336.HK)](https://longbridge.com/zh-CN/quote/01336.HK.md) - [CSEC/China Shenhua (601088.CN)](https://longbridge.com/zh-CN/quote/601088.CN.md) - [China Shenhua Energy (CSUAY.US)](https://longbridge.com/zh-CN/quote/CSUAY.US.md) - [CHINA SHENHUA (01088.HK)](https://longbridge.com/zh-CN/quote/01088.HK.md) - [R&F PROPERTIES (02777.HK)](https://longbridge.com/zh-CN/quote/02777.HK.md) - [SHIMAO GROUP (00813.HK)](https://longbridge.com/zh-CN/quote/00813.HK.md) - [NAYUKI (02150.HK)](https://longbridge.com/zh-CN/quote/02150.HK.md) - [GANFENGLITHIUM (01772.HK)](https://longbridge.com/zh-CN/quote/01772.HK.md) - [SH PHARMA (02607.HK)](https://longbridge.com/zh-CN/quote/02607.HK.md) - [SHYNDEC (600420.CN)](https://longbridge.com/zh-CN/quote/600420.CN.md) - [HEYTEA (HEYTEA.NA)](https://longbridge.com/zh-CN/quote/HEYTEA.NA.md) - [Hengrui Pharma (600276.CN)](https://longbridge.com/zh-CN/quote/600276.CN.md) - [TENGEN (003003.CN)](https://longbridge.com/zh-CN/quote/003003.CN.md) - [PING AN (02318.HK)](https://longbridge.com/zh-CN/quote/02318.HK.md) - [SSY GROUP (02005.HK)](https://longbridge.com/zh-CN/quote/02005.HK.md) - [China Meheco (600056.CN)](https://longbridge.com/zh-CN/quote/600056.CN.md) - [TIBET AIM PHARM (002826.CN)](https://longbridge.com/zh-CN/quote/002826.CN.md) - [TY PHAR. (002728.CN)](https://longbridge.com/zh-CN/quote/002728.CN.md) - [Lifeon Pharmaceutical (003020.CN)](https://longbridge.com/zh-CN/quote/003020.CN.md) ## 相关资讯与研究 - [A Look At China Life Insurance (SEHK:2628) Valuation After Strong 2025 Earnings And Proposed Final Dividend](https://longbridge.com/zh-CN/news/281251717.md) - [Guangzhou R&F Properties Revamps Board and Committees Ahead of 2026 AGM](https://longbridge.com/zh-CN/news/281182304.md) - [China Cinda Asset Management FY net profit attributable rmb3,562.3 million](https://longbridge.com/zh-CN/news/281172966.md) - [Ping An targets doubling valuation as 60% of claims go automated](https://longbridge.com/zh-CN/news/281231549.md) - [China Shenhua Sets 2026 Plan to Boost Value, Output and Technological Edge](https://longbridge.com/zh-CN/news/281061064.md)